Skip to main content
SpringerLink
Log in

Trizyklische Antidepressiva zur Initialbehandlung einer depressiven Episode? Pro

Tricyclic antidepressants for initial treatment of depressive episodes? Pro

  • Pro und Kontra
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Adli M, Baethge C, Heinz A et al (2005) Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci 255:387–400

    Article  PubMed  Google Scholar 

  2. Adli M, Pilhatsch M, Bauer M et al (2008) Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression. Pharmacopsychiatry 41:252–257

    Article  CAS  PubMed  Google Scholar 

  3. Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58:19–36

    Article  CAS  PubMed  Google Scholar 

  4. Barbui C, Furukawa TA, Cipriani A (2008) Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials. CMAJ 178:296–305

    Article  PubMed  PubMed Central  Google Scholar 

  5. Bschor T (2015) Antidepressiva verhindern nicht Suizidversuche oder Suizide. Nervenarzt 86:1168–1170

    Article  CAS  PubMed  Google Scholar 

  6. Bschor T (Hrsg) (2008) Behandlungsmanual therapieresistente Depression. Pharmakotherapie – somatische Therapieverfahren – Psychotherapie. Kohlhammer, Stuttgart

    Google Scholar 

  7. Bschor T (2010) Therapy-resistant depression. Expert Rev Neurother 10:77–86

    Article  PubMed  Google Scholar 

  8. Bschor T, Bauer M, Adli M (2014) Chronic and treatment resistant depression: diagnosis and stepwise therapy. Dtsch Arztebl Int 111:766–775

    PubMed  PubMed Central  Google Scholar 

  9. Bschor T, Härter M, Schauenburg H (2011) Antidepressiva bei leichten depressiven Störungen – Kontra. Psychiatr Prax 38:270–273

    Article  PubMed  Google Scholar 

  10. Bschor T, Müller-Oerlinghausen B (2014) Antidepressiva verringern nicht das Risiko von Suiziden oder Suizidversuchen bei depressiven Patienten. Eine Entgegnung zur Presseerklärung der Deutschen Gesellschaft für Psychiatrie, Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN). Arzneiverordn Prax 41:2–5

    Google Scholar 

  11. Bschor T, Munk I (2014) Antidepressiva verringern nicht die Rate an Suizidversuchen oder Suiziden. Psychiatr Prax 41:55–56

    Article  Google Scholar 

  12. DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW für die Leitliniengruppe Unipolare Depression (Hrsg.) (2015) S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, 2. Auflage, Version 1, November 2015. DGPPN, ÄZQ, AWMF, Berlin, Düsseldorf

  13. Dhippayom T, Chaiyakunapruk N, Jongchansittho T (2011) Safety of nortriptyline at equivalent therapeutic doses for smoking cessation: a systematic review and meta-analysis. Drug Saf 34:199–210

    Article  CAS  PubMed  Google Scholar 

  14. Fergusson D, Doucette S, Glass KC et al (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 330:396

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Furukawa T, Mcguire H, Barbui C (2003) Low dosage tricyclic antidepressants for depression. Cochrane Database Syst Rev 3:CD003197

    PubMed  Google Scholar 

  16. Gillman PK (2007) Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. Br J Pharmacol 151:737–748

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Guaiana G, Barbui C, Hotopf M (2007) Amitriptyline for depression. Cochrane Database Syst Rev 2:CD004186

    Google Scholar 

  18. Häuser W, Wolfe F, Tölle T et al (2012) The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs 26:297–307

    Article  PubMed  Google Scholar 

  19. Hiemke C, Baumann P, Bergemann N et al (2011) AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry 44:195–235

    Article  Google Scholar 

  20. Köhler S, Stover LA, Bschor T (2014) MAO-Hemmer als Behandlungsoption der therapieresistenten Depression: Anwendung, Wirksamkeit und Besonderheiten. Fortschr Neurol Psychiatr 82:228–236

    Article  PubMed  Google Scholar 

  21. Leucht C, Huhn M, Leucht S (2012) Amitriptyline versus placebo for major depressive disorder. Cochrane Database Syst Rev 12:CD009138

    PubMed  Google Scholar 

  22. Lewitzka U (2008) Irreversible MAO-Hemmer. In: Bschor T (Hrsg) Behandlungsmanual therapieresistente Depression. Pharmakotherapie – somatische Therapieverfahren – Psychotherapie. Kohlhammer, Stuttgart, S 102–113

    Google Scholar 

  23. Lynch ME (2001) Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci 26:30–36

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Onghena P, Van Houdenhove B (1992) Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 49:205–219

    Article  CAS  PubMed  Google Scholar 

  25. Rabenda V, Nicolet D, Beaudart C et al (2013) Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos Int 24:121–137

    Article  CAS  PubMed  Google Scholar 

  26. Schauenburg H, Bschor T (2013) Sollten leichte Depressionen ausschliesslich psychotherapeutisch behandelt werden? Pro. Nervenarzt 84:386–387

    Article  CAS  PubMed  Google Scholar 

  27. Schueler YB, Koesters M, Wieseler B et al (2011) A systematic review of duloxetine and venlafaxine in major depression, including unpublished data. Acta Psychiatr Scand 123:247–265

    Article  CAS  PubMed  Google Scholar 

  28. Seitz DP, Gill SS, Conn DK (2010) Citalopram versus other antidepressants for late-life depression: a systematic review and meta-analysis. Int J Geriatr Psychiatry 25:1296–1305

    Article  PubMed  Google Scholar 

  29. Sommer C, Häuser W, Alten R et al (2012) Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline. Schmerz 26:297–310

    Article  CAS  PubMed  Google Scholar 

  30. Stone M, Laughren T, Jones ML et al (2009) Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 339:b2880

    Article  PubMed  PubMed Central  Google Scholar 

  31. Strubel T, Birkhofer A, Mossmer G et al (2010) Blutungsrisiko unter SSRI-Behandlung. Nervenarzt 81:549–555

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Psychiatrie, Schlosspark-Klinik, Heubnerweg 2, 14059, Berlin, Deutschland

    T. Bschor

  2. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Deutschland

    T. Bschor

Authors
  1. T. Bschor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Bschor.

Ethics declarations

Interessenkonflikt

T. Bschor hat seit Juni 2014 keine finanziellen Beziehungen mehr zu pharmazeutischen Herstellern. Davor hatte er Vortragshonorare der Firmen Lilly, Lundbeck, AstraZeneca, BMS, Servier, Bayer und Aristo sowie eine Kongressreiseunterstützung durch Lundbeck angenommen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bschor, T. Trizyklische Antidepressiva zur Initialbehandlung einer depressiven Episode? Pro. Nervenarzt 87, 558–560 (2016). https://doi.org/10.1007/s00115-015-0035-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-015-0035-3

Search

Navigation